Literature DB >> 30847507

Heart failure and diabetes: management and open issues.

K Schütt1, N Marx2.   

Abstract

Diabetes mellitus is an important comorbidity in patients with heart failure. The presence of heart failure in diabetes worsens the prognosis of patients. Recent studies suggest that appropriate diagnostic approaches followed by differential medical treatment are of crucial importance to improve patient outcomes. This article summarizes important aspects of the association between diabetes mellitus and heart failure.

Entities:  

Keywords:  Cardiac failure; Diabetic cardiomyopathy; Diagnosis; Pathophysiology; Therapy

Mesh：

Year:  2019        PMID： 30847507     DOI： 10.1007/s00059-019-4792-9

Source DB:  PubMed          Journal:  Herz        ISSN： 0340-9937            Impact factor:   1.443


  42 in total

Review 1.  Cardiovascular effects of incretin-based therapies.

Authors:  Michael Lehrke; Nikolaus Marx
Journal:  Rev Diabet Stud       Date:  2011-11-10

2.  Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.

Authors:  John A Dormandy; Bernard Charbonnel; David J A Eckland; Erland Erdmann; Massimo Massi-Benedetti; Ian K Moules; Allan M Skene; Meng H Tan; Pierre J Lefèbvre; Gordon D Murray; Eberhard Standl; Robert G Wilcox; Lars Wilhelmsen; John Betteridge; Kåre Birkeland; Alain Golay; Robert J Heine; László Korányi; Markku Laakso; Marián Mokán; Antanas Norkus; Valdis Pirags; Toomas Podar; André Scheen; Werner Scherbaum; Guntram Schernthaner; Ole Schmitz; Jan Skrha; Ulf Smith; Jan Taton
Journal:  Lancet       Date:  2005-10-08       Impact factor: 79.321

3.  Metformin use and mortality in ambulatory patients with diabetes and heart failure.

Authors:  David Aguilar; Wenyaw Chan; Biykem Bozkurt; Kumudha Ramasubbu; Anita Deswal
Journal:  Circ Heart Fail       Date:  2010-10-15       Impact factor: 8.790

4.  Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study.

Authors:  Hossein Bahrami; David A Bluemke; Richard Kronmal; Alain G Bertoni; Donald M Lloyd-Jones; Eyal Shahar; Moyses Szklo; João A C Lima
Journal:  J Am Coll Cardiol       Date:  2008-05-06       Impact factor: 24.094

5.  The incidence of congestive heart failure in type 2 diabetes: an update.

Authors:  Gregory A Nichols; Christina M Gullion; Carol E Koro; Sara A Ephross; Jonathan B Brown
Journal:  Diabetes Care       Date:  2004-08       Impact factor: 19.112

6.  Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial.

Authors:  Jean-Louis Chiasson; Robert G Josse; Ramon Gomis; Markolf Hanefeld; Avraham Karasik; Markku Laakso
Journal:  JAMA       Date:  2003-07-23       Impact factor: 56.272

7.  Pioglitazone use and heart failure in patients with type 2 diabetes and preexisting cardiovascular disease: data from the PROactive study (PROactive 08).

Authors:  Erland Erdmann; Bernard Charbonnel; Robert G Wilcox; Allan M Skene; Massimo Massi-Benedetti; John Yates; Meng Tan; Robert Spanheimer; Eberhard Standl; John A Dormandy
Journal:  Diabetes Care       Date:  2007-07-31       Impact factor: 19.112

8.  Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme.

Authors:  Michael R MacDonald; Mark C Petrie; Fumi Varyani; Jan Ostergren; Eric L Michelson; James B Young; Scott D Solomon; Christopher B Granger; Karl Swedberg; Salim Yusuf; Marc A Pfeffer; John J V McMurray
Journal:  Eur Heart J       Date:  2008-04-14       Impact factor: 29.983

9.  Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure.

Authors:  Ida Gustafsson; Bente Brendorp; Marie Seibaek; Hans Burchardt; Per Hildebrandt; Lars Køber; Christian Torp-Pedersen
Journal:  J Am Coll Cardiol       Date:  2004-03-03       Impact factor: 24.094

10.  Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.

Authors:  David Aguilar; Scott D Solomon; Lars Køber; Jean-Lucien Rouleau; Hicham Skali; John J V McMurray; Gary S Francis; Marc Henis; Christopher M O'Connor; Rafael Diaz; Yuri N Belenkov; Sergei Varshavsky; Jeffrey D Leimberger; Eric J Velazquez; Robert M Califf; Marc A Pfeffer
Journal:  Circulation       Date:  2004-09-13       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.